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Abstract
We systematically reviewed the evidence on secular trends in main chronic conditions, dis-
ability and self-assessed general health among adults in the United Kingdom, as reported in
primary/secondary care databases and population-based surveys. Searches were con-
ducted separately for: (1) trends in age-standardised or age-specific prevalence of major
non-communicable diseases, disability, and self-reported general health; (2) trends in health
expectancy. The databases searched were MEDLINE, EMBASE/EMBASE Classic and
Web of Science (all from 1946/7). The evidence was synthesised narratively. There were 39
studies reporting trends in prevalence of health conditions and 15 studies in health expec-
tancy. We did not find evidence for improvement in the age-standardised or age-specific
prevalence of any of the studied major chronic conditions over the last few decades, apart
from Alzheimer’s disease and other dementias. Both increasing or stable prevalence rates
with simultaneous rising life expectancy support the expansion of morbidity theory, meaning
that people are expected to spend a greater number of years with chronic condition(s). The
evidence on disability—expressed as prevalence or health expectancy—was mixed, but
also appeared to support the expansion of morbidity among those aged 65 or over. The evi-
dence on trends in disability for younger age is lacking. Across the studied period (1946–
2017), the UK population endured more years with chronic morbidity and disability, which
may place a serious strain on the health care system, the economy and the society.
Introduction
The period following World War II saw dramatically increasing life expectancy at birth in the
United Kingdom, from 66.3 years in 1946 to 82.0 in 2015.[1] This was primarily due to rising
longevity among older adults, with 65 year olds in 2014 having a further life expectancy of 19.7
years compared with 13 years in 1951.[1] It has to be noted, however, that despite continuous
increase in life expectancy, the current improvements are not as optimistic as they were, partic-
ularly among the older population.[2] It is unclear how population health has evolved along
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with increasing life expectancy, for example, whether these additional years of life have been
spent in good health. This issue needs to be addressed to inform public policy, for instance, to
determine if older people have the capacity to remain in employment for additional years.[3]
To date, three main theories have been proposed to explain population health change:
expansion of morbidity, compression of morbidity and dynamic equilibrium (Table 1). In our
review, we considered two sources of evidence, which have been rarely interpreted simulta-
neously in the context of the theories: trends in age-standardised or age-specific prevalence
rates as well as in health expectancy and total life expectancy. The most pessimistic scenario,
the expansion of morbidity theory, alludes that gains in unhealthy years are greater than those
in healthy ones.[4] Hence, due to rising life expectancy, stable or rising trends in age-specific
prevalence rates would lead to expansion. The most optimistic theory—compression of mor-
bidity—states that health expectancy is rising faster than total life expectancy; meaning that
age-specific prevalence of morbidity is declining over time.[4] The third theory, dynamic equi-
librium, proposes that there is an overall increase in prevalence and years of morbidity, which,
however, has a mildly disabling effect.[5] Dynamic equilibrium would also occur when mor-
bidity neither expands nor compresses as both mortality and morbidity are postponed by an
equal number of years (see Table 1).[5] Interpreting evidence from the perspective of these the-
ories helps to emphasise the necessity to improve population health to compensate the conse-
quences of increasing lifespan. Hence, only reduction in morbidity over time can be
considered as a positive scenario for public health.
The above theories have been developed around morbidity defined as disability associated
with chronic conditions.[6] Hence, health expectancies are typically estimated based on a self-
rated general health or an indicator if one suffers from longstanding illness or disability. This
provides a limited picture of overall trends in health. Studying parallel trends of all aspects of
population health change, including disability or specific chronic conditions, would lead to
more precise policy recommendations, and support the design and monitoring of interven-
tions.[7] For instance, costs of chronic conditions to the individual and society extend beyond
their disabling effects, through medical costs, sub-clinical damage to health or psychosocial
and stress-related burden associated with being labelled as diseased.[6] Other health measures,
such as self-reported general health, has been demonstrated to be a strong predictor of mortal-
ity and disability, even while controlling for a range of objective health measures. [8, 9] This
measure may capture a multifaceted nature of health—including morbidity as well as health
awareness and expectations.[8, 9] Moreover, considering simultaneous trends in various mea-
sures of morbidity is essential for understanding the needs for care resources. For instance,
increasing burden of chronic diseases would imply greater need for medical care, whereas ris-
ing limitations in activities (e.g. in walking or lifting) indicates a growing demand for rehabili-
tation, assistive technology and social services related to personal assistance as well as for a
better adapted environment.[10] Hence, we refer to morbidity as an umbrella term for chronic
Table 1. Interpretation of findings in the context of the main population health change theories in the present
study.
Study findings Interpretation
• Decrease in age-specific/age-adjusted prevalence of morbidity
• Greater increase in health expectancy than in total life expectancy
Compression of
morbidity
• Increase or no change in age-specific/age-adjusted prevalence of morbidity
• Greater increase in total life expectancy than in health expectancy
Expansion of morbidity
• Increase or no change in age-specific/age-adjusted prevalence of mild morbidity and
decrease in age-specific/age-adjusted prevalence of severe morbidity
• Equal increase in health expectancy and total life expectancy
Dynamic equilibrium
https://doi.org/10.1371/journal.pone.0218991.t001
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conditions, disability, self-perceived poor health as well as other health measures commonly
used to estimate health expectancy.
Overall, there is little consensus on which—if any—of these stylised scenarios best describes
recent trends and, it seems that much depends on the health conditions used to operationalise
morbidity and disability. Two systematic reviews of this topic have been conducted. One in
the USA, which found overall declines in mild old-age disability between 1990 and 2002,
whereas conflicting findings were observed for more severe long-term disability.[11] The sec-
ond review was also limited to older population and period between 1991 and 2011, but did
not make any geographical restrictions. It concluded that chronic morbidity measures tended
to point towards expansion of morbidity, whereas disability-related measures somewhat
inconsistently produced evidence for compression of morbidity. Other European studies
investigating trends in the last three decades have found evidence for all three scenarios: com-
pression in fair or poor self-perceived health[12, 13] and disability,[14] expansion of morbidity
due to chronic diseases, moderate mobility limitation[15] and mild disability.[16, 17] Available
non-systematic reviews of the evidence in the UK tend to emphasise the inconclusive and scat-
tered nature of the evidence.[18, 19] The Global Burden of Disease Study (GBD), using a vast
array of data sources from both published literature and primary analyses in the UK popula-
tion, produced evidence supporting expansion of morbidity theory.[20, 21] It concluded that
people spent more years in poor health in 2010 compared with 1990, as the increase in the
number of years in good health was smaller than the rise in life expectancy at birth.[20] This
was mainly due to reductions in age-specific mortality, and largely unchanged prevalence of
major health conditions (weighted by an estimate of how disabling those were).[13] Nonethe-
less, the GBD study included information on trends only from 1990 and provided little evi-
dence on health outcomes other than chronic conditions, such as self-rated general health or
disability.
Hence, we aimed to systematically review the evidence on trends in multiple health out-
comes—expressed as prevalence rates and health expectancy—including main chronic condi-
tions as well as disability, and self-reported general health among adults in the UK during the
period of 1946–2017. This would provide a more holistic picture of population health trends
in the UK and further our understanding of the inconsistencies in the evidence. We included
information from both primary/secondary care databases and population-based surveys,
which have different strengths and sources of bias. For instance, routinely collected data may
be more sensitive to introduction of screening programmes or changes over time in health
awareness, as they rely on population presented to health services. Whereas, population-based
surveys may mitigate this bias by studying the same, pre-defined population. On the other
hand, population-based surveys are likely to report sporadic points in time, compared to rou-
tinely collected data that have information year-by-year. Triangulation of information from
these sources allowed for attaining a more reliable evidence on the population health trends.
[22] Our review also includes a wider period of time (1946–2017) than the previous reviews,
considering long-lasting population health changes that have taken place in the UK.
Methods
Search strategy and selection criteria
In order to evaluate post-war trends in morbidity among adults (16 years old or older), two
types of primary outcomes were retrieved: (1) estimates of trends in age-specific or age-stan-
dardised prevalence of major chronic non-communicable conditions, disability, and self-
reported general health and (2) estimates of trends in health expectancy–which were not
defined based on a specific health measure due to an overall small number of studies
Post-war (1946-2017) population health change in the UK
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estimating health expectancy. In addition, studies of trends in incidence were retrieved as a
secondary outcome. They, however, did not provide direct evidence on the theories of popula-
tion health change but may help to explain current, and predict future, trends in prevalence
(see S1 File for a brief summary of the evidence on incidence). In the current study, we defined
morbidity as (1) chronic morbidity (i.e. a persistent condition or otherwise long-lasting in its
effects), (2) disability, (3) self-reported poor health. We also included studies using a question
on limiting longstanding illness or disability, typically used in health expectancy estimates.
The review focused on major contributors to chronic morbidity, hence included conditions
must have accounted for at least 1 per cent of disability-adjusted years of life (DALYs) in the
UK from non-communicable diseases according to the Global Burden of Diseases Study 2010
(GBD) (coronary heart disease, stroke, chronic obstructive pulmonary disease, asthma, diabe-
tes, Alzheimer‘s disease migraine, cirrhosis, musculoskeletal pain).[17] Colorectal and breast
cancer as well as osteoarthritis were also included, however studies of trends in prevalence
have not been found. The disability measures followed a wide definition of disability by the
World Health Organisation, which covers impairments (i.e. a problem in body function or
structure) and activity limitations (a difficulty in executing a task or action).[7] We also
included indicators of activities of daily living (ADLs), often considered as sever disability (e.g.
difficulties with bathing), and instrumental activities of daily living (IADLs), an indicator of
mild disability (e.g. difficulties with shopping).[7]
Measures of self-reported general health were also included as they have been found partic-
ularly useful for population health monitoring due to being highly predictive of mortality and
use of health services.[23] To meet the inclusion criteria, studies: (1) drew on population-
based probability samples (having longitudinal or cross-sectional design) or primary/second-
ary care databases and other routinely collected data, (2) were conducted in the UK, (3) were
published in English. Studies providing estimates of incidence/prevalence at a single point in
time were excluded.
Separate searches for health expectancy and incidence/prevalence studies were conducted
by the main author (DG) (example in Table 2). In addition, reference lists of all included stud-
ies, Google Scholar and OpenGrey Repository were screened to identify any other eligible
studies. The study protocol was registered with the International Prospective Register of Sys-
tematic Reviews (PROSPERO) (registration number: CRD42017069291).
Table 2. The search strategy in OvidSP (including EMBASE AND MEDLINE).
Search structure for studies capturing trends in the prevalence/incidence
Concept Trends AND Health indicators AND Study design
Examples of key words change in incidence OR change in prevalence OR
trends in incidence
self-rated health OR SRH
OR stroke
cohort� OR prospective OR
retrospective OR panel
Search structure for studies capturing trends in the health expectancy
Concept Trends AND Health expectancy
Examples of key words increase� OR rise� OR gain� OR difference� health� life expectanc� OR health expectancy
OR active life expectanc�
Searched fields abstracts, key words, titles, text word, keyword heading word
Limits applied 13+; English only; Article only, human only, removed duplicates
Truncation command
used
’root word�’: captures alternative word endings
To note. Searches were conducted in MEDLINE (from 1946), EMBASE (1980–2017) and EMBASE Classic (1947–1973) via OvidSP interface and Web of Science (from
1946).
An asterisk (�) was used to truncate search terms.
https://doi.org/10.1371/journal.pone.0218991.t002
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Data collection
Titles and abstracts were screened independently by two reviewers (DG & KN) according to
exclusion/inclusion criteria. Full texts were retrieved for all citations that were included by
either reviewer. The eligibility of all full texts was also assessed by two reviewers (DG & KN).
Any disagreements were resolved by discussion. The key information was extracted from all
publications (available upon request) by the first author (DG). In addition, the information
from 20 per cent of all the publications was extracted by the second reviewer (KN) to ensure
reliability and discrepancies were resolved by discussion.
Risk of bias assessment
Two reviewers independently assessed the risk of bias within all sources of data according to
the criteria broadly based on the Newcastle-Ottawa Quality Assessment Scale (see S2 File).[24]
These criteria included: (1) sample being representative of the UK population; (2) high validity
and reliability of outcome assessment; (3) consistency in methodology over time. Other poten-
tial biases—not related to the data source itself—were discussed in relation to each outcome.
An example could be ascertainment bias resulting from the introduction of screening pro-
grammes. The evidence was considered of high quality (free of major biases) if all three criteria
were met, two met criteria indicated moderate quality and evidence with one or none met cri-
terion was considered of low quality. Tables 3–9 indicate data sources used for each outcome
as well as overall quality of body of evidence. The detailed assessment of quality of each data
source can be found in S3 File.
Table 3. The characteristics of evidence on prevalence of each health outcome, with the emphasis on size, consistency and quality.
Health outcome and
data source
(n studies)†
Period Age
(range)
Conclusion & consistency of findings on trends Overall quality of evidence † †
Coronary heart disease
(n = 6):
QOF (n = 1)[53]
HSE/S (n = 2)[25, 53]
GLS/GHS (n = 1)[53]
National Morbidity
Survey (n = 1)[25]
BRHS (n = 1)[30]
CMR (n = 1)[40]
THIN (n = 1)[39]
MRC CFAS (n = 1)[42]
1955-6-
2013-4
All Expansion for the entire period (mixed findings
on trends: stable or increasing prevalence)
High
+ representative of the population;
+ low risk of bias related to outcome assessment, combination
of both self-reports and linkage of medical records;
+ highly comparable methodology over time;
= lack of strong evidence on other biases
Stroke (n = 4):
QOF (n = 1)[53]
HSE/S (n = 2)[25, 53]
GLS/GHS (n = 1)[53]
National Morbidity
Survey (n = 1)[25]
MRC CFAS (n = 1)[42]
GPRD (n = 1)[43]
1970-1-
2013-4
All Expansion for the entire period (mixed findings
on trends: stable or increasing prevalence)
High
+ representative of the population;
+ low risk of bias related to outcome assessment combination
of both self-reports and linkage of medical records;
+ highly comparable methodology;
= lack of strong evidence on other biases
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t003
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Synthesis of evidence
Meta-analysis of trends or cumulative reporting of year-by-year estimates were not feasible
due to vast differences across studies in reporting of the estimates (e.g. prevalence rates per
100,000 person years at risk, estimates of proportion of the population who have the condition,
annual % change over the studied period), as well as in definition of health outcomes, and lack
of information on year-by-year estimates. Hence, this review reports on consistency in the
overall trends across studies, focusing on comparability of methodology over time. The evi-
dence is summarised narratively, and trends estimates are provided throughout the study from
the data sources of highest quality. Findings are reported separately for periods 1950s-1990s
and 1990s-2010s as well as for each morbidity outcome, either based on health expectancy or
prevalence estimates. A majority of the studies provided age-standardised estimates for entire
adult population (‘All’ in Age column of Tables 3–9) or older individuals (65-year-old or
older)–hence reporting of the results is focused on those two age groups.
Results
Study selection
Our literature searches identified 6141 citations examining trends in prevalence and incidence
and 2186 for trends in health expectancy (see Fig 1). After removing duplicates and studies
Table 4. The characteristics of evidence on prevalence of each health outcome, with the emphasis on size, consistency and quality (cont.).
Health outcome and
data source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Lung cancer (n = 1):
THIN (n = 1)[59]
2004–
2012
All Expansion for the entire period
(consistent findings on trends: increase in
prevalence)
High
+ representative of the population;
+ low risk of bias related to outcome assessment, based on linkage of
medical records;
+ highly comparable methodology;
= lack of strong evidence on other biases
COPD (n = 2):
QRESEARCH (n = 1)
[58]
GPRD (n = 1)[55]
1990–
2005
All Expansion for the entire period
(consistent findings on trends: increase in
prevalence)
Low
+ representative of the population;
+ low risk of bias related to outcome assessment, linkage of medical records;
however spirometry data not available for checking reliability of diagnoses
= no information on comparability of methodology over time;
- possible ascertainment bias due to introduced incentives to create and
maintain a registry of patients with COPD
Asthma (n = 3):
QRESEARCH (n = 1)
[57]
GPRD (n = 1)[56]
BHPS (n = 1) [46]
1990–
2005
15+ Expansion for the entire period
(consistent findings on trends: increase in
prevalence)
Low
+ representative of the population;
+ low risk of bias related to outcome assessment, based on linkage of
medical records; however spirometry data not available for checking
reliability of diagnoses
= no information on comparability of methodology over time;
- publicity and awareness campaigns on asthma in the lay and medical
arenas, and diagnostic bias, might play a role in the reported increase in
asthma prevalence
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t004
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conducted outside of the UK, the initial screening of titles and abstracts was conducted by two
reviewers–reaching a high agreement (Kappa = 0.78). This narrowed the number of full texts
for retrieval to 65 for prevalence/incidence and 56 for health expectancy. These papers were
assessed for eligibility by two reviewers (Kappa = 0.69), the main reason for exclusion was inel-
igibility of the outcome. Twenty papers reported incidence trends exclusively and were
excluded at this stage. After inclusion of papers from other sources (see Fig 1), the total sample
included 39 studies reporting trends in chronic morbidity and 15 in health expectancy.
Period 1950s – 1990s
The trends in prevalence of chronic morbidity clearly support the expansion of morbidity sce-
nario for the period of 1970s-1990s, across all ages and sexes. There was evidence pointing
towards expansion in coronary heart diseases occurring from as early as 1950s (see Tables 3–
7). Similarly, the evidence consistently points towards expansion in limiting longstanding
morbidity (including illness or disability), self-reported general health at birth and among
older people for the period of 1970s-1990s, and of more severe disability (with stable preva-
lence trends) between early 1980s and mid-1990s (see Tables 3–9). However, there is some evi-
dence that more severe disability may have declined among the oldest participants (75 or
Table 5. The characteristics of evidence on prevalence of each health outcome, with the emphasis on size, consistency and quality (cont.).
Health outcome and
data source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Alzheimer‘s disease/other
dementias (n = 2):
MRC CFAS (n = 1)[61]
ELSA (n = 1)[60]
1989–
2013
50+ Compression for the entire period (consistent findings on trends:
decrease in prevalence)
High
+ representative of older population;
+ low risk of bias related to outcome
assessment, based on cognitive assessment;
+ highly comparable methodology over
time;
= possible non-response bias, however, it
was addressed by sensitivity analyses
= lack of strong evidence on other biases
Migraine (n = 1)
BHPS (n = 1)[46]
1991–
1998
All Expansion (increase in prevalence) Low
+ representative of the population;
- no detailed information on the outcome
assessment, based on self-reports;
= no information on comparability of the
methodology over time
= lack of strong evidence on other biases
Low back pain (n = 2):
Arthritis Research
Campaign (n = 1)[26]
Randomly selected from
lists of GPs (n = 1)[27]
1956
-1997-8
18–64 Expansion for the entire period (consistent findings: increase in
prevalence of less disabling back pain, no difference in prevalence of
more disabling back pain)
Low—representativeness limited to the
northwest region of England;
- no information on possible biases due to
outcome assessment, based on self-reports;
- changes to mode of data collection and
definitions of the outcome;
= lack of strong evidence on other biases
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t005
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Table 6. The characteristics of evidence on prevalence of each health outcome, with the emphasis on size, consistency and quality (cont.).
Health outcome and data
source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Diabetes (n = 13):
MRC CFAS (n = 1)[42]
DIN (n = 1)[49]
DARTS (n = 1)[44]
Routine hospital data (Cardiff/
Vale of Glamorgan) (n = 1)[50]
Hospital diabetes register
(n = 1)[28]
THIN (n = 2)[45, 54]
GPRD (n = 1)[51]
HSE/S (n = 6)[47, 48, 52, 71]
BRHS (n = 1)[29]
GLS (n = 1)[48]
1979–
1984
2013
All Expansion for the entire period
(consistent findings on trends:
increase in prevalence)
High
+ representative of the population;
+ low risk of bias related to outcome assessment, combination of both
self-reports and linkage of medical records;
+ highly comparable methodology over time;
= lowered criteria for diagnosis of diabetes by fasting plasma glucose
values from�7.8 to 7.0 mmol/l in 2000, however, the rate of increase
in incidence is similar before and after 1999;
= possible ascertainment bias due to, introduction of incentives for
general practitioners to better detect cases (the Quality and Outcomes
Framework in 2004), however sensitivity analyses showed little impact
and the increase too large to be explained solely by ascertainment bias
Cirrhosis (n = 1):
GPRD (n = 1)[72]
1992–
2001
25+ Expansion (increase in prevalence) Moderate
+ representative of the population;
+ no information on the outcome assessment, based on linkage of
medical records;
= no information on comparability of the methodology over time
= lack of strong evidence on other biases
Self-rated general health
(n = 2):
BHPS (n = 1)[46]
General practices in
Leicestershire (n = 1)[37]
1981–
2008
75+ Expansion (increase in prevalence) Low
+ representative of the population;
= no detailed information on the outcome assessment;
= no information on comparability of the methodology over time
= lack of evidence on other biases
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t006
Table 7. The characteristics of evidence on prevalence of each health outcome, with the emphasis on size, consistency and quality (cont.).
Health outcome and data source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Disability (n = 7):
MRC CFAS (n = 1)[42]
ELSA (n = 1)[69]
General practices in Gloucestershire
(n = 1)[68]
General practices in Leicestershire
(n = 1)[36]
GHS (n = 2)[31, 48]
Family Resource Survey (n = 1)[65]
HSE (n = 2)[48, 73]
1979–
2012
50+ Expansion 1979–1994 (consistent findings on
trends: stable prevalence)
Expansion 1994–2012 (mixed findings on trends)
High
+ representative of the population;
+ low risk of bias related to outcome assessment,
based on self-reports;
+ highly comparable methodology over time;
= lack of evidence on other biases
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t007
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older) between early 1980s and mid-1990s, supporting compression of morbidity for that
period (see Tables 3–9).
Chronic morbidity. All included studies for this period reported trends in prevalence
rates, rather than in health expectancy. Studied chronic conditions were coronary heart dis-
ease, stroke, musculoskeletal pain and diabetes. The National Morbidity Survey, including a
representative sample of General Practitioners (GPs), reported increasing prevalence of angina
from mid-1950s to 1990s, particularly among those aged 65 or older (e.g. it increased by 128%
for the period of 1972–1992) and of stroke between 1971 and 1991 in all age and sex groups
(increased by 40%).[25] The overall trends in the prevalence of myocardial infarction were
inconsistent: prevalence rates increased slightly between 1971 and 1981 (by 15%) and subse-
quently fell between 1981 and 1991 (by 31%).[25] One study also reported higher point preva-
lence of self-reported musculoskeletal pain (e.g. cervical, dorsal) in 1994–95 compared with
1956–58.[26] However, population representativeness of the study was limited to a small
north-eastern region of England and the measure of musculoskeletal pain as well as demo-
graphic characteristics somewhat varied between the surveys.[26] In another study—represen-
tative for the population and with identical methodology over time—sex- and age-
standardised prevalence of self-reported back pain (lasting for at least 24 hours in previous 12
months) increased between 1987-8 and 1997-8 (by 12% in absolute terms).[27] However,
severe back pain (self-reported ability to put on hosiery) fell minimally by 0.7% (-0.1%, 1.5%)
among 29-59-year-olds.[27] The increase in age- and sex-standardised prevalence was also
seen in diabetes between 1978 and 1996 in two large surveys conducted in primary care prac-
tices.[28, 29] According to the British Regional Heart Study, which is a representative cohort
Table 8. The characteristics of evidence on health expectancy, with the emphasis on size, consistency and quality.
Health outcome and data source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Limiting long-standing illness or
disability (n = 10):
GHS/GLS (n = 7)[32–35, 41, 62,
63]
UK Census (n = 2)[64, 66]
MRC CFAS (n = 1)[67]
1976–
2014
All At birth: Expansion 1976–1995; expansion for 2001–
2014 (consistent)
Age 65/85: Expansion for the entire period (consistent)
High
+ representative of the population (includes
institutionalised population);
+ low risk of bias related to outcome assessment;
+ consistent methodology over time;
= lack of evidence on other biases.
Self-rated general health (n = 6):
HSE (n = 1)[38]
MRC CFAS (n = 1)[67]
GHS/GLS (n = 4)[33, 41, 62, 74]
1981–
2014
0, 15, 65,
85
At birth/15: Expansion 1981–1999 (consistent);
expansion for 2000–2011 (inconsistent)
Age 65/85: Expansion for the entire period (consistent)
High
+ representative of the population (includes
institutionalised population);
+ low risk of bias related to outcome assessment;
+ consistent methodology over time;
= lack of evidence on other biases.
Disability (n = 2):
GHS/GLS (n = 1)[32]
MRC CFAS (n = 1)[67]
1985–
2011
65+ 1980–1994: Compression among 75-year-old or older
1991–2011: Expansion
High
+ representative of the population (includes
institutionalised population);
+ low risk of bias related to outcome assessment;
+ consistent methodology over time;
= lack of evidence on other biases.
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends)
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t008
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of 7722 British males aged 40–59, the annual age-adjusted rate of diabetes rose by 4.3% (0.4%,
8.2%) in the period 1978–1985 and 5.5% (3.0%, 8.1%) in 1985–1992.[29] In the same study,
lifetime prevalence of coronary heart disease stayed stable in the period 1978–1985 and
increased (annual % change in odds: 1.9%, 0.5% to 3.3%) in 1985–1992.[30]
Limiting longstanding morbidity. The proportion of older individuals (age 60–89)
reporting a limiting longstanding illness, disability or infirmity in the General Household Sur-
vey increased from late-1970s until late 1980s, and tailed off in the 1990s –averaging at 42%.
[31] Due to rising life expectancy, this resulted in an increase of over three years in life-time
expectancy with limiting long-term ill-health.[32] Greater increase in life expectancy than the
total number of years without a limiting long-standing illness or disability was also seen in
other studies for overlapping period, both at birth and at age 65 or over.[33–35]
Disability. The analysis of the General Household Survey showed largely stable rates in
ADLs (i.e. self-reported ability to independently bath, shower or wash all over) and mobility
measures (i.e. self-reported ability to manage stairs and steps)—among aged 75 or older—
between 1980 and 1994.[31, 32] However, there was evidence for reductions in disability
among participants 85 years old or older, particularly among males.[31, 32] For instance, 18%
of males reported one or more ADLs in 1994 compared with 31% in 1980.[32] The increase in
health expectancy was comparable with the total life expectancy—hence overall number of
years expected to be lived with disability remained stable.[32] A repeated cross-sectional sur-
vey including only 75 years old or older population of Melton Mowbray (Leicestershire, UK),
Table 9. The characteristics of evidence on health expectancy, with the emphasis on size, consistency and quality (cont.).
Health outcome and data
source
(n studies)†
Period Age
(range)
Conclusion & consistency of results Overall quality of evidence † †
Measures of cognition
(n = 1):
MRC CFAS (n = 1)[67]
1991–
2011
65+ Compression of morbidity for females and
expansion for males
High
+ representative of the population (includes institutionalised
population);
+ low risk of bias related to outcome assessment, based on
cognitive assessment;
+ consistent methodology over time;
= lack of evidence on other biases.
Summary health variable
(n = 1):
BHPS (n = 1)[46]
1991–
1998
20–80 Expansion of morbidity for all ages Low
+ representative of the population;
= no detailed information on the outcome assessment;
= no information on comparability of the methodology over
time;
= lack of evidence on other biases.
Other health outcomes
(n = 1):
HSE (n = 1)[41]
1991–
2014
25–64 Expansion of morbidity for all ages High
+ representative of the population (includes institutionalised
population);
+ low risk of bias related to outcome assessment, based on
cognitive assessment;
+ consistent methodology over time;
= lack of evidence on other biases.
† Some studies included more than one data source.
†† Quality criteria were representativeness of the sample of the UK population; risk of bias due to outcome assessment; comparability of the methodology over time;
other biases affecting comparability of trends. Meeting 3 criteria indicates high quality of evidence, 2 moderate, 1/0 low quality of evidence (high risk of bias in
comparability of trends).
’+’ = no risk of bias
’-’ = risk of bias
’ = ’ = no information on risk of bias
https://doi.org/10.1371/journal.pone.0218991.t009
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also found decrease in age-adjusted prevalence of most ADLs (i.e. getting in and out of bed/a
chair, dressing, getting to and from the toilet, bathing) between 1981 and 1988.[36] However,
the study may be not representative for the UK population.
Self-rated general health. Life expectancy increased more than health expectancy with
self-rated ‘good’ or ‘fairly good’ health—by 0.4 years—for those aged 65 for the period between
1981 and 1995.[33] Likewise, more recently born cohorts had a greater proportion of elderly
people who rated their health as ‘less than good’ between 1981 and 1988 (e.g. by 17% among
those aged 75–81).[37] The estimates were also robust to effects of migration over time.[37]
Similar results were found for the period of 1981–1995 for health expectancy at birth, when
the expected number of years lived in poor health increased by 1.3 years,[33] and for 1994–
1999 among individuals aged 15 –with the increase by 0.9 years.[38]
Period 1990s – 2010s
The trends in chronic morbidity consistently pointed towards expansion of morbidity across
ages with rising prevalence in all studied conditions except for dementias, especially Alzhei-
mer’s disease (decreasing trend in prevalence in 1990–2010) and coronary heart disease (stable
in 2000–2010) (see Tables 3–7 and Fig 2). The expansion of morbidity was apparent due to
long-standing illness or disability (as a self-reported one item indicator)—particularly among
those aged 65 or older, where increase in health expectancy did not compensate for the
increase in total life expectancy. Overall, expansion of morbidity in disability was also more
apparent among older population (65-year-old or older), however there was a considerable
inconsistency in the evidence with trends varying depending on specific measures used. Stud-
ies on disability trends among younger population were lacking. There was a clear trend for
Fig 1. Flow chart for selection of papers and sources included in the review. �One study reported both prevalence and health expectancy.
https://doi.org/10.1371/journal.pone.0218991.g001
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expansion of morbidity in self-reported general health for the entire period and across all ages
and sexes. Finally, we found compression of morbidity for cognitive impairment among
females (but expansion among males).
Chronic morbidity. All included studies reported trends in prevalence rates, rather than
in health expectancy. Chronic conditions found for this period were coronary heart disease,
stroke, lung cancer, COPD, asthma, Alzheimer‘s disease and other dementias, migraine, cir-
rhosis, low back pain and diabetes.
According to the British Regional Heart Study, the age-standardised prevalence of coronary
heart disease declined minimally (the trend was not statistically significant) among 40–59
year-old males in the period 1992–1996 (annual % change in odds: -1.4%, -3.0% to 0.2%).[30]
High quality evidence—based on large primary/secondary care databases and population-
based surveys, with consistent methodology over time—indicated increasing age-standardised
prevalence rates between mid-1990s and mid-2000s in all ages and sexes for: coronary heart
diseases,[25, 39–41] stroke[25, 41–43] and diabetes.[28, 29, 44–52] Based on large primary
care databases—the Health Improvement Network (THIN) and the General Practice Research
Database (GPRD)—average percentage change in age-standardized prevalence of coronary
heart disease increased by 1.5% for the period 1996–2005;[39] unstandardised stroke preva-
lence increased by 13%, from 6.40/1000 in 1999 to 7.20/1000 in 2008;[43] and crude prevalence
of diabetes prevalence increased from 2.8% in 1996 to 4.3% in 2005 (age- and sex-standardisa-
tion did not make a substantial difference).[45]
More recently, studies of trends in coronary heart disease between early-2000s and early-
2010s, based on both general practice records (the Quality and Outcomes Framework; THIN)
and population-representative annual cross-sectional surveys (the National Health Surveys
and the General Household Survey), concluded that the prevalence of coronary heart disease
remained largely stable,[25, 30, 39, 40, 53] whereas rates of stroke[53] and diabetes[54]
increased (respectively by 13% and 123% in relative terms).
Similarly, high-quality evidence, based both on primary/secondary databases and popula-
tion-based surveys, indicated an increase in prevalence of chronic respiratory diseases (asthma
and chronic obstructive pulmonary disease) from early 1990s to mid-2000s.[46, 55–58] For
instance, according to the QRESEARCH, there was a relative increase in the standardised
prevalence of COPD (by 24%) and of asthma (by 20%) between 2001 and 2005.[57, 58] The
British Household Panel Survey (BHPS) also reported an increase in self-reported migraine
between 1991 and 1998 in both males and females across most of the age groups, particularly
65 or older.[46] A study using THIN showed that age- and sex-standardised prevalence rates
of lung cancer rose by 23% between 2004 and 2012, mainly due to increases among females.
[59] We found two high-quality prospective longitudinal studies, the English Longitudinal
Study of Ageing (ELSA) and the Medical Research Council Cognitive Function and Ageing
Studies (MRC CFAS I and II), both representative of the older population, aged 50 or older
and 65 or older respectively.[60, 61] Both studies showed a relative decrease in age and sex-
standardised prevalence of dementia by 30% for the period of 2002/2003-2012/3 and by 40%
for 1989–2011.[60, 61]
Limiting longstanding morbidity. Large population-based surveys, representative for the
UK population and with consistent methodology over time (GHS/GLS, the Integrated House-
hold Survey, Continuous Household Survey and the UK census data), all found that the total
Fig 2. Summary of the evidence for the period (1990–2010), for those aged 16–64 (Panel A) and 65 or older (Panel B). Each bar indicates compression/dynamic
equilibrium/expansion of morbidity in a given health condition for either males or females. Darker shades represent high confidence in findings, with evidence being
consistent and of high quality (see Tables 3–9). Lighter shades represent inconsistent evidence or of low quality.
https://doi.org/10.1371/journal.pone.0218991.g002
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life expectancy has increased by a greater number of years than life expectancy without a limit-
ing longstanding illness or disability at age 65 or older for the period between early-1990s and
early-2010s.[62–64] For instance, estimates based on the National Census showed increase by
0.4 years for 85-year-olds between 1991 and 2001.[64] However, there is some evidence that
between 2002 and 2012, those born after 1924 experienced lower odds of having long-standing
illness, disability or infirmity, whereas the prevalence was stable for females.[65] However,
among people who reported longstanding morbidity, the number of disabilities increased (e.g.
mobility, manual dexterity) for each successive cohort (incidence rate ratio 1.03), suggesting
greater severity of morbidity.[65]
The findings for trends at younger ages were inconsistent, however overall pointing
towards a greater increase in total life expectancy than health expectancy. Wohland and col-
leagues [64] found a total life expectancy increased by 1.3 years more than health expectancy
in the period of 1991–2001. Similar findings were obtained for a shorter period of 2001–2011,
based on the UK National Census data from London only (expansion of morbidity by 1.7
years).[66] On the contrary, estimates based on the GHS/GLS showed a greater increase in
health expectancy than total life expectancy—for males only (with no difference among
females)—in the shorter period of 2000–2011 (by 0.9 year).[62, 63] Finally, a study based on
repeated annual cross-sections of the Health Survey for England from 1991 to 2014 (partici-
pants aged 25–64), found an equal increase in health expectancy and total life expectancy.[41]
Disability. There was an increase of 2.5 years with self-reported ADLs (e.g. putting on
shoes and socks) and IADLs (e.g. shopping) in the period of 1991–2011 among 65-year-old.
[67] The findings were somewhat mixed among studies that provided age-standardised preva-
lence rates. These inconsistencies were found despite overlapping study periods, comparable
populations and definitions of disability. The analysis of the Health Survey for England indi-
cated increasing rates of severe disability (e.g. washing/bathing, dressing) among 65-year-olds,
up from 13.5% in 1995 to 15.3% in 2001.[48] By contrast, the results from the General House-
hold Survey indicated a decline in severe disability rates among people aged 65 and over, from
21 per cent in 1994–95 to 18 per cent in 2001–2.[48] The reasons for the diverging results are
not clear. In studies with multiple indicators of disability, the trends were also mixed–regard-
less of severity of disability or type of activity. For instance, a repeated cross-sectional study in
England, conducted between 1998 and 2008, found reductions in sex-standardised disability
rates among those aged 75 or older in outdoor mobility, washing difficulty, ability to prepare a
meal, joint pain and requiring help with nail care, whereas differences were not found in dress-
ing difficulty, indoor mobility and prevalence of falls.[68] Similarly, a study using the HSE—
conducted among 65 years and older in 1992–2007—found decreasing age-adjusted preva-
lence in usual activities, stable rates in limitations in self-care activities and increasing rates in
limitations in walking 200 yards and climbing stairs. Chatterji and colleagues found declining
proportion of people aged 50–75, but not 75 or older, with severe disability (ADLs) in 2002–
2008.[69] Whereas, proportion of individuals with mild disability (IADLs) increased over the
period across all ages, with a sharper rise among 75-year-old or older.[69] In the only study
with younger population, a greater proportion of 25-year-old or older reported problems or
disability related to arms, legs, hands, feet, back or neck.[46]
Self-rated general health. The findings somewhat consistently showed that life expec-
tancy increased more than expected years with self-reported ‘good’ health for those aged 65 for
the period between early-1990s and mid-2010s (by 0.6 year).[62, 67] Similar findings were
obtained for individuals at age 15 in 1994–1999 –with a greater increase in life expectancy than
health expectancy by 0.9 year.[38] Contradictory findings were produced by a study using the
GHS/GLS, which showed that years with self-rated good health at birth increased by 1.3 years
more than total life expectancy in 2000–11.[62] However, the response option changed during
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the observation period, hence the reliability of the findings is questionable.[62] The inconsis-
tencies in the methodology were accounted for statistically in another study, which focused on
England only and included a longer period (2000–2014). [70] The study showed that total life
expectancy increased more at birth than years with self-rated good health by 0.9.[70] A greater
increase in total life expectancy than health expectancy was also found by Jivraj and colleagues,
for the period of 1991–2014 among participants aged 25–64.[41]
Measures of cognition. A study estimating health expectancy without cognitive
impairment between 1991 and 2011 at age 65 found that health expectancy increased more
than total life expectancy among females (by 0.8 years).[67] Whereas for males, the number of
years without cognitive-impairment lagged behind increase in life expectancy (by 0.3 years).
[67]
Discussion
Summary of findings
This is the first systematic review of evidence on the joint progress of health and mortality in
the UK. We assessed trends of morbidity, based on large population-based surveys and pri-
mary/secondary care databases or other routinely collected data. The trends in prevalence of
chronic morbidity clearly support the expansion of morbidity scenario for the entire period of
1970s to mid-2010s across all ages, with some evidence pointing towards expansion in coro-
nary heart diseases occurring already from 1950s. Rising prevalence was observed in all studied
conditions except for coronary heart disease that appears to have been stable in the period of
2000s-2010s (still supporting expansion of morbidity scenario) and Alzheimer‘s disease and
other dementias (1989–2013)–reflecting compression of morbidity in severe cognitive
impairment (particularly among females).[67] Likewise, the evidence consistently points
towards expansion in limiting longstanding morbidity (including illness or disability) and self-
reported general health, both at birth and among older people, for the period of 1980s-2010s.
For those measures increase in health expectancy lagged behind the increase in total life expec-
tancy. The evidence based on measures of disability, such as daily activities (e.g. mobility, self-
care) was inconsistent. It appears that there was compression of morbidity in severe disability
(with stable prevalence trends) between early 1980s and mid-1990s. Overall, expansion of mor-
bidity in disability among older population appears to be the more likely scenario in the period
1990s-2010s. The evidence on disability measures in lacking for younger age is lacking, with
one study pointing towards expansion of morbidity.
Comparison with other evidence
Findings from our review were largely consistent with the GBD study providing support for
the expansion of morbidity for: diabetes, lung cancer, stroke, asthma, chronic obstructive pul-
monary disease, migraine.[20, 21] Inconsistencies were found for Alzheimer‘s and other
dementias as GBD found no difference in prevalence rates over time (expansion of morbidity),
while studies included in our review suggested a decrease (compression of morbidity).[20, 21]
This, however, again may be due to different age distribution of the sample (all vs 50-year-olds
or older) and definition of ‘caseness’. As far as coronary hearts disease is concerned, GBD
found no difference among females (expansion of morbidity) and decrease among males
(compression of morbidity) over time, whereas our review suggested increase in both sexes
(expansion of morbidity). Overall, our findings seem to be consistent with the GBD study,
which found that health expectancy—based on the overall prevalence of a range of health out-
comes multiplied by the disability weights—has increased to a lesser extent than total life
expectancy (3.2 vs 4.2 years).[20] This finding is true for all EU15+ countries, although the
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difference between the increase in life expectancy at birth and health expectancy varied from
0.5 years in Greece to 1.7 years in Luxembourg.[20] Chatterji and colleagues also found expan-
sion of chronic morbidity for the period 1991–2011 in worldwide studies, whereas no discern-
ible patterns across countries or within countries over time emerged in disability.[69]
Explanations for the findings
There are several potential explanations for our findings. The improved survival (e.g., from
stroke and some cancers), due to more effective disease management,[19, 39, 40, 49, 54]
appears to lead to a higher prevalence of morbidity and an increase in the number of people
living with disorders that previously would have been fatal.[20, 21] Although there is some evi-
dence for declining incidence in coronary heart diseases or stroke, these decreases appear to
lag behind improvements in survival (see S1 File). For other conditions, such as diabetes, the
incidence has increased in the last three decades–hence further expansion of morbidity is
expected (S1 File).
It is also likely that more effective screening, combined with greater health awareness—
rather than the actual burden of chronic diseases—have contributed to the rising rates. For
instance, there has been some concerns that asthma may be currently overdiagnosed in pri-
mary care, after years of underdiagnosis.[75] Also, the quality of recording tends to improve
over time, particularly after adopting new computer systems, which may lead to higher esti-
mates.[76] Moreover, rising rates of morbidity may be partially caused by programmes incen-
tivising accurate maintenance of registers of patients with diseases such as asthma or diabetes
(e.g. the New General Medical Services Contract[77]). However, studies that limited their anal-
ysis to services with highly accurate data—as a sensitivity check—tended to find similar
trends–for instance in diabetes.[49] Interpretability of trends in diabetes specifically, is also
limited by lowering of plasma glucose threshold for diagnoses of diabetes in 2000, which did
result in an initial sharp increase in diagnosis in early 2000s.[54] Nonetheless, the rising trends
in diabetes have been consistently observed before and after 2000. Moreover, prevalence of
diabetes also increased as indicated by haemoglobin A1c (HbA1c), in addition to self-reported
diagnosis.[41, 71]
The trends in chronic health should also be considered in the context of trends in risk fac-
tors. These, however, are inconsistent over time with some important risk factors decreasing
since 1990s, for instance systolic blood pressure, total cholesterol, smoking or heavy drinking,
[25, 41, 71, 73, 78] and others increasing–obesity, hypertension and sedentary lifestyle.[25, 41,
71] It also appears that overall there was a greater decline in risk factors more strongly associ-
ated with mortality (e.g. smoking) than morbidity (e.g. obesity), hence providing a partial
explanation for expansion of morbidity.[79] It is important to note that individuals with less
education and of manual social class experienced relatively worse trends in risk factors over
time.[65, 73] This has increased the health gap between those of low and high socioeconomic
position.[65, 73]
It is also important to note that people‘s knowledge and expectations about health may
have improved over time, due to better education,[80] which might have raised propensity to
report health problems and to have higher expectations from health services. However, empiri-
cal evidence testing this hypothesis is lacking. There are still inconsistencies regarding reports
of IADL (e.g. independence in shopping) and, more severe, ADL disability (e.g. independence
in bathing). Declines in IADLs, should be expected, partially due to improvements in the envi-
ronment, for instance, wheelchair access or availability of ready-made meals or microwave
ovens.[10] However, similar aids are difficult to implement for ADLs.[10] Hence declines in
this type of disability may be less likely to occur, unless secondary and tertiary care is more
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successful in offsetting disabling effects of rising chronic diseases, for which there is currently
no evidence.
Implications
Our review is the first one conducted systematically, which provides a comprehensive and crit-
ical insight into the existing evidence. Overall, the rates of morbidity as well as time spent in
morbid states, have increased in the last three decades. This is, partially, due to remarkable
improvement in survivorship with most chronic conditions. A similar success story is needed
in preventing disabling effect of chronic morbidity, as its prevalence is expected to rise,[81]
and in delaying the onset of chronic morbidity. Currently there is no evidence for effective
practices in either of these processes–with a potential exception for the most severe morbidi-
ties, for example related to effective control of hypertension prior to stroke.[43]
A holistic approach to prevention ought to account for an accumulation of health risks
across the lifespan–starting in childhood.[7] Hence, an effective approach needs to address
modifiable risk factors, which origin in early life–including alcohol consumption, smoking,
sedentary lifestyle and diet. Specific recommendations for tackling these problems have been
developed. For instance, the National Institute for Health and Care Excellence emphasised the
need to recognise the alcohol consumption problem early and act both at the population level
(e.g. by reducing marketing of harmful substances) and the individual level (e.g. cognitive-
behavioural skills training).[82] Nonetheless, it is important to recognise that risk factors clus-
ter and accumulate to a greater extent among those of low socioeconomic position.[83] People
of manual social class or low education lagged behind more advantaged groups in their
improvement in life expectancy, and to even a greater extent, in health expectancy–dispropor-
tionally extending their time lived with morbidity.[63, 64] These inequalities were also seen at
the national level (Scotland having worse outcomes than England) and regional level (North-
ern England having greater burden of morbidity than Southern England).[53, 57, 58] Again,
regional variability was larger in mortality than morbidity.[84] These socioeconomic differ-
ences appear to be greater in the rates of risk factors, rather than in disease management.[40,
57, 84] Overall, this emphasises the need for health policies and interventions targeted at par-
ticularly vulnerable groups, in order to close the health gap between rich and poor. In addition,
these efforts ought to be more focused on morbidity prevention, where the largest inequalities
exist, rather than disease management.
As the prevalence of morbidity is projected to increase in the next decade, it is also neces-
sary to consider how the additional years of life can be managed: to ensure good quality of life,
and reduce financial consequences of already existing morbidity.[85] For instance, McCor-
mick and colleagues [86] argued that we should move beyond focus on healthcare and pen-
sions, creating more innovative practices leading to harnessing everyday relationships,
enabling older individuals to continue paid or unpaid work, encouraging lifelong learning and
building environment that helps to connect older people to services, activities, and other peo-
ple.[86] Such practices have already been successfully implemented around the world and
could be adapted to the UK context (e.g. Healthy Ageing Evidence Review [87]).
Limitations and future research
Research on disability suffers from methodological inconsistencies leading to mixed findings,
which has been repeatedly pointed out in the literature.[11, 79] Also, as it is the case in the
USA, data on changes in prevalence of disability and functioning problems are scarce and gen-
erally limited to the older population.[19] Disability can occur at any time in life, and research
on disability at all ages is requisite.[88] More research is needed, which would address
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limitations of current disability measures, particularly using objectively measured disability as
these are not affected by response bias and are more comparable over time. Moreover, disabil-
ity measures are often based on a single question, thus the use of instruments with finer grada-
tion of disability severity should be more common.[88, 89] This would allow for the testing of
dynamic equilibrium theory and better understanding of the reasons underlying disability
trends. Furthermore, future research should combine various health indicators obtained
within the same individuals, mainly chronic conditions and disability.[46] Such approach
would help to understand if disease management also improves one‘s quality of life–in addi-
tion to prolonging survivorship. Another limitation of the literature was that very few studies
included the institutionalised population,[61] as the changes in the prevalence of institutionali-
sation over time may lead to under-/overestimation of prevalence of certain diseases. A few
studies that took that into account did not, however, find any difference in estimates—due to
overall low proportion of the institutionalised population.[61, 65]
Conclusion
The evidence on trends in prevalence of chronic conditions strongly suggests expansion of
morbidity. The increasing prevalence of chronic morbidity may to some extent reflect better
diagnostics, but as rising trends occur within short studied periods, it is an unlikely explana-
tion for trends. The trends in disability are less conclusive, however even if the length of life
with disability remains the same but the length of life needing treatment for disease increases,
lifetime health costs will increase unless the cost of health care are reduced.[19] Thus, there is
an urgent need for preventative efforts that would delay the onset of morbidity.
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